Related Experiment Videos
[Treatment of severe refractory pemphigus vulgaris with rituximab]
Gerard Pitarch1, José L Sánchez-Carazo, José Pardo
1Servicio de Dermatología, Hospital General Universitario de Valencia, Spain. gerardpitarch@hotmail.com
Abstract:
Pemphigus vulgaris is a potentially fatal autoimmune bullous disease. High doses of immunosuppressive drugs are used in managing severe cases of pemphigus. Rituximab, an anti-CD20 monoclonal antibody, has proven to be effective in patients with refractory pemphigus vulgaris and pemphigus foliaceus. We review cases of pemphigus vulgaris and pemphigus foliaceus not associated with lymphoma that were treated with rituximab, and we report a new case of severe refractory pemphigus vulgaris successfully treated with rituximab.
Related Concept Videos
Rocky Mountain Spotted Fever
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...